ConductScience.org, home

Paper229941

Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.

MacGregor GA and 3 others. Br Med J, 1979. Cited by 66 papers, by iCite.

Cite this record

ConductScience Library. Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme. Papers, record 229941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/229941

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.
PubMed
Journal
Br Med J
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
66
iCite
Relative citation ratio, by iCite
3.64
iCite
Revised in PubMed
2019-05-01
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1MacGregor GAG A
2Markandu NDN D
3Roulston JEJ E
4Jones JCJ C

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CaptoprilMajor topic
HypertensionMajor topic
ProlineMajor topic
Adult
Aged
Angiotensin-Converting Enzyme Inhibitors
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Renin

Source PubMed

Download CSV of topics

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1232490Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension1979https://conductscience.org/library/papers/232490PubMed
266571A specific orally active inhibitor of angiotensin-converting enzyme in man.Lancet1977https://conductscience.org/library/papers/66571PubMed
3205788Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man.N Engl J Med1978https://conductscience.org/library/papers/205788PubMed
4195203Accentuated vascular and endocrine response to SQ 20881 in hypertension.N Engl J Med1977https://conductscience.org/library/papers/195203PubMed
5191908Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.Science1977https://conductscience.org/library/papers/191908PubMed
6185903Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.Am J Med1976https://conductscience.org/library/papers/185903PubMed
7679493Measurement of plasma renin activity by radioimmunoassay after prolonged cold storage.Clin Chim Acta1978https://conductscience.org/library/papers/679493PubMed
8837471Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.Circ Res1977https://conductscience.org/library/papers/837471PubMed
9973974Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man.Br J Clin Pharmacol1976https://conductscience.org/library/papers/973974PubMed
101103909Clinical experience with use of ultrasound sphygmomanometer.Br Heart J1975https://conductscience.org/library/papers/1103909PubMed
111245602Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man.J Clin Invest1976https://conductscience.org/library/papers/1245602PubMed

Download CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.

PMIDTitleJournalYearIn PapersSource
8597776How adverse drug reactions can play a role in innovative drug research.Pharm World Sci1995https://conductscience.org/library/papers/8597776PubMed
8198936Dose finding studies with imidapril--a new ACE inhibitor.Br J Clin Pharmacol1994https://conductscience.org/library/papers/8198936PubMed
7946796ACE inhibitors for heart failure: a question of dose.Br Heart J1994https://conductscience.org/library/papers/7946796PubMed
7026256Haemodynamic profile of captopril treatment in various forms of hypertension.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7026256PubMed
7009133Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.Drugs1980https://conductscience.org/library/papers/7009133PubMed
6802291Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6802291PubMed
6758826Heart rate control in hypertensive patients treated by captopril.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6758826PubMed
6387264Captopril in Cushing's syndrome.Klin Wochenschr1984https://conductscience.org/library/papers/6387264PubMed
6308066Angiotensin-converting enzyme and its clinical significance--a review.J Clin Pathol1983https://conductscience.org/library/papers/6308066PubMed
6282372Relation of plasma renin activity to the antihypertensive effect of MK 421 in the rat.Br J Pharmacol1982https://conductscience.org/library/papers/6282372PubMed
6266576Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects.Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6266576PubMed
6259406Captopril in various forms of severe therapy-resistant hypertension.Klin Wochenschr1981https://conductscience.org/library/papers/6259406PubMed
6159943Inhibitors of angiotensin I converting enzyme for treating hypertension.Br Med J1980https://conductscience.org/library/papers/6159943PubMed
3886905Captopril for refractory hypertension in patients with impaired renal function.J R Soc Med1985https://conductscience.org/library/papers/3886905PubMed
3520132Minoxidil and captopril in severe hypertension.Klin Wochenschr1986https://conductscience.org/library/papers/3520132PubMed
3103761Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study.Br Med J (Clin Res Ed)1987https://conductscience.org/library/papers/3103761PubMed
2537217Safety and tolerance of single oral doses of trandolapril (RU 44.570), a new angiotensin converting enzyme inhibitor.Eur J Clin Pharmacol1989https://conductscience.org/library/papers/2537217PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACE1636PubTator's text mininghttps://conductscience.org/library/genes/1636NCBI Gene
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/229941

GET https://conductscience.org/api/papers/v1/229941/authors